Thomas Budd
Professor, Department of Medicine, School of Medicine · Case Western Reserve University
Credentials: · · · ·
History
1980–1982- 1977–1980
Research
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
New England Journal of Medicine · 2004 · 3,524 citations
Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer
Journal of Clinical Oncology · 2005 · 853 citations
Clinical Cancer Research · 2006 · 800 citations
- RB
47 papers
- RT
27 papers
- TO
20 papers
18 papers
14 papers
13 papers
13 papers · 7 as a resident
12 papers
Grants
- 1978–2009
National Cancer Institute · U10
Contact PI · $3.6M · Cleveland Clinic Lerner Com-Cwru
- 1999–2002
Phase Ii Clinical Study of a Selective Estrogen Receptor
National Cancer Institute · N01
Contact PI · $692.3K · Cleveland Clinic Foundation
- 1995–2001
Phase i/Pharmacokinetic Trials of Limonene
National Cancer Institute · N01
Contact PI · Cleveland Clinic Foundation
- 1995–1997
Phase i Multiple Dose Safety & Pharmacokinetic Clinical
National Cancer Institute · N01
Contact PI · $369.1K · Cleveland Clinic Foundation
Clinical trials
- 2021–2025
Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer
Principal investigator · Completed · Early phase 1
George T. Budd
- 2003–2027
S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
Study chair · Active not recruiting · Phase 3
SWOG Cancer Research Network
- 2002–2010
Study chair · Completed · Phase 2
Case Comprehensive Cancer Center
- 2001
Study chair · Unknown · Phase 1
The Cleveland Clinic